| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |